Influence of specific collagen peptides on repair processes of articular cartilage in patients with knee osteoarthritis - a randomized, comparative, double-blind study
- Conditions
- M17Gonarthrosis [arthrosis of knee]
- Registration Number
- DRKS00024095
- Lead Sponsor
- Steinbeis-Transferzentrum 1172
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
knee joint complaints of arthritic genesis
-arthritis of the knee joint according to Kellgren-Lawrence stage II-III
-no acute traumatic injury of the knee joint
-no indication of inflammatory (rheumatic/bacterial/viral) genesis of the pain symptoms
-intra-articular injections (cortisol, hyaluronic acid, etc.) in the last 6 months
-intake of chrondroprotective dietary supplements (glucoasmin, chrondroitin, etc.) in the last 6 months
-intake of collagen peptides or UC-II collagen in the last 6 months
-extreme pain symptoms requiring high-dose analgesic therapy over a prolonged period (>2 weeks) or intra-articular injection treatment or surgical therapy
-intolerance to ingredients of the dietary supplement to be tested
-no consumption of animal products or pork products
-known allergy/reaction to contrast media used in medical diagnostics (especially dotarem)
-known bronchial asthma or allergy
-kidney disease
-liver disease
-past or upcoming organ transplantation
-symptomatic cardiovascular disease
-treatment with a beta blocker
-known cramping disorder
-existing pregnancy or desire to have children
-very poor arm veins
-metallic, magnetic and electronic implants, pacemakers, prostheses or other foreign bodies
-expressed claustrophobia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method